Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Talbert

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|February 1, 1991
The bleeding time effects of a single dose of aspirin in subjects receiving omega-3 fatty acid dietary supplementationB A Mueller, R L Talbert, C H Tegeler, et al.
Clinical Pharmacy|January 1, 1982
Diagnosis and treatment of Prinzmetal's variant anginaM T McMahon, M A McPherson, R L Talbert, et al.
Journal of Medical Education|September 1, 1980
A longitudinal study of personality characteristics of medical studentsA G Burstein, S Loucks, J Kobos, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1985
Population pharmacokinetics of racemic warfarin in adult patientsD R Mungall, T M Ludden, J Marshall, et al.
Stroke|May 22, 1998
Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research GroupR A Kronmal, R G Hart, T A Manolio, et al.
Journal of Pharmaceutical Sciences|July 1, 1984
Plasma protein binding of warfarin: methodological considerationsD Mungall, Y Y Wong, R L Talbert, et al.
Pharmacotherapy|August 6, 1998
Thrombolytic therapy for acute myocardial infarctionF L Meister, K A Stringer, S A Spinler, et al.
Clinical Pharmacology and Therapeutics|March 1, 1982
Clodronate kinetics and bioavailabilityG J Yakatan, W J Poynor, R L Talbert, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyR L Talbert, P Gal, G E Dukes, et al.
Pharmacotherapy|May 1, 1993
Pharmacotherapy specialty certification examination. IV. 1992 results and process modifications, including recertification. The 1992 Specialty Council on Pharmacotherapy, Board of Pharmaceutical SpecialtiesB J Zarowitz, P H Vlasses, G E Dukes, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|February 1, 1991
The bleeding time effects of a single dose of aspirin in subjects receiving omega-3 fatty acid dietary supplementationB A Mueller, R L Talbert, C H Tegeler, et al.
Clinical Pharmacy|January 1, 1982
Diagnosis and treatment of Prinzmetal's variant anginaM T McMahon, M A McPherson, R L Talbert, et al.
Journal of Medical Education|September 1, 1980
A longitudinal study of personality characteristics of medical studentsA G Burstein, S Loucks, J Kobos, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1985
Population pharmacokinetics of racemic warfarin in adult patientsD R Mungall, T M Ludden, J Marshall, et al.
Stroke|May 22, 1998
Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research GroupR A Kronmal, R G Hart, T A Manolio, et al.
Journal of Pharmaceutical Sciences|July 1, 1984
Plasma protein binding of warfarin: methodological considerationsD Mungall, Y Y Wong, R L Talbert, et al.
Pharmacotherapy|August 6, 1998
Thrombolytic therapy for acute myocardial infarctionF L Meister, K A Stringer, S A Spinler, et al.
Clinical Pharmacology and Therapeutics|March 1, 1982
Clodronate kinetics and bioavailabilityG J Yakatan, W J Poynor, R L Talbert, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyR L Talbert, P Gal, G E Dukes, et al.
Pharmacotherapy|May 1, 1993
Pharmacotherapy specialty certification examination. IV. 1992 results and process modifications, including recertification. The 1992 Specialty Council on Pharmacotherapy, Board of Pharmaceutical SpecialtiesB J Zarowitz, P H Vlasses, G E Dukes, et al.
Pageof 6